Inactive Instrument

Highlights SANOCHEMIA Pharmazeutika AG

Equities

EOSS Technology GmbH, Wirtschaft Burgenland GmbH – WiBuG and b·e·imaging·GmbH acquired SANOCHEMIA Pharmazeutika AG from bew Beteiligungs GmbH and other shareholders.	15/20/15	CI
Bew Beteiligungs GmbH acquired an unknown stake in SANOCHEMIA Pharmazeutika AG from Inphasearch AG.	10/20/10	CI
SANOCHEMIA Pharmazeutika AG Announces Positive Topline Results from Phase 2 Star Study of Tolperisone in Acute Muscle Spasms of the Back in the U.S	24/19/24	CI
B·e·imaging·GmbH acquired 14.5% stake in SANOCHEMIA Pharmazeutika AG from Inphasearch AG.	18/19/18	CI
Sanochemia Pharmazeutika Ag Reports Earnings Results for the Six Months of the Year 2018	24/18/24	CI
Sanochemia Pharmazeutika AG Announces Sales Results for the First Quarter of Fiscal 2017; Provides Earnings Guidance for the Full Year of Fiscal 2017	23/17/23	CI
Invesa AG and Inphasearch AG cancelled the acquisition of 34.9% stake in Sanochemia Pharmazeutika AG from Sanochemia Ltd.	22/17/22	CI
Sanochemia Announces Earnings Results for the Full Year of Fiscal 2016	31/16/31	CI
Invesa AG and Inphasearch AG agreed to acquire 34.9% stake in Sanochemia Pharmazeutika AG from Sanochemia Ltd.	22/16/22	CI
Sanochemia Extends Contracts with Janssen N.V	16/15/16	CI
Sanochemia Reports Preliminary Earnings Results for the Fiscal Year 2013	10/13/10	CI
Link Healthcare Obtains Extensive Regional Rights to Secrelux from Sanochemia Pharmazeutika AG	14/13/14	CI
Sanochemia Pharmazeutika AG's Equity Buyback has expired	22/12/22	CI

No results for this search